Notice

mylife Diabetescare is no longer part of the Ypsomed Group. Click here to visit the website.

  • English
  • German
  • 中文
Skip navigation
  • Media
  • Investors
 
Logo
Skip navigation
  • Our products
    • Product finder
    • Pen injectors
      • UnoPen
      • ServoPen
      • YpsoPen
      • YpsoFlow
      • FixPen
      • LyoTwist
      • VarioJect
    • Autoinjectors
      • YpsoLoop
      • YpsoMate
      • YpsoMate 2.25 / Pro
      • YpsoMate 5.5
      • SmartPilot for YpsoMate
      • CliniPilot
      • VarioJect
    • Wearable injectors
      • YpsoDose
    • Digital Health
      • Therapy management
      • Connected devices
      • Resources
    • Innovation Hub
      • YpsoDot
      • YpsoGoFLEX
      • YpsoGoECO
    Spotlight

    Good solutions come full circle

    Discover YpsoLoop
  • Our expertise
    • Track record
    • Modular platforms
      • Platform development
      • Customization process
      • Scalability
    • Manufacturing
      • Precision tooling
      • Injection molding
      • Assembly
    • Partner network
      • Final assembly services
      • Final assembly equipment
      • Packaging and labeling equipment
      • Device testing equipment
    • Services
      • Regulatory
      • Intellectual property
      • Testing & design verification
      • Quality
      • Sustainability services
      • Clear to Clinic
    Spotlight

    Streamline clinical development with Ypsomed

    Learn more
  • News & insights
    • Product news
    • Company stories
    • Press releases
    • Blog
    • Events
    • Resources
    Spotlight

    Ypsomed to establish first U.S. manufacturing facility

    Read news
  • Careers
    • Working in Switzerland
      • Professionals
      • Young professionals
      • Open jobs
    • Working in Germany
      • Open jobs
  • About us
    • Management
    • Corporate strategy
    • Sustainability
    • Global presence
    • History
    • Suppliers
  • Contact
 
  • English
  • German
  • 中文
Skip navigation
  • Media
  • Investors
 
Skip navigation
  • Our products
    • Product finder
    • Pen injectors
      • UnoPen
      • ServoPen
      • YpsoPen
      • YpsoFlow
      • FixPen
      • LyoTwist
      • VarioJect
    • Autoinjectors
      • YpsoLoop
      • YpsoMate
      • YpsoMate 2.25 / Pro
      • YpsoMate 5.5
      • SmartPilot for YpsoMate
      • CliniPilot
      • VarioJect
    • Wearable injectors
      • YpsoDose
    • Digital Health
      • Therapy management
      • Connected devices
      • Resources
    • Innovation Hub
      • YpsoDot
      • YpsoGoFLEX
      • YpsoGoECO
    Spotlight

    Good solutions come full circle

    Discover YpsoLoop
  • Our expertise
    • Track record
    • Modular platforms
      • Platform development
      • Customization process
      • Scalability
    • Manufacturing
      • Precision tooling
      • Injection molding
      • Assembly
    • Partner network
      • Final assembly services
      • Final assembly equipment
      • Packaging and labeling equipment
      • Device testing equipment
    • Services
      • Regulatory
      • Intellectual property
      • Testing & design verification
      • Quality
      • Sustainability services
      • Clear to Clinic
    Spotlight

    Streamline clinical development with Ypsomed

    Learn more
  • News & insights
    • Product news
    • Company stories
    • Press releases
    • Blog
    • Events
    • Resources
    Spotlight

    Ypsomed to establish first U.S. manufacturing facility

    Read news
  • Careers
    • Working in Switzerland
      • Professionals
      • Young professionals
      • Open jobs
    • Working in Germany
      • Open jobs
  • About us
    • Management
    • Corporate strategy
    • Sustainability
    • Global presence
    • History
    • Suppliers
  • Contact
 

Annual General Meeting

  • Investors
  • Annual General Meeting

Documents related to the AGM 2025

  • Invitation to the Annual General Meeting 2025 (171.8 KiB)
  • Agenda items and proposals of the Board of Directors (96.6 KiB)
  • Agenda item 5; Amendments to the Articles of Association: introduction of a capital band (57.5 KiB)

Next AGM

01
07

General meeting 2026

The next Annual General Meeting of Ypsomed Holding AG will be held on Wednesday, 1 July 2026.

Read more...General meeting 2026
Minutes of all past AGMs (in German)
  • Minutes of meeting AGM 2025 (4.1 MiB)
  • Minutes of meeting AGM 2024 (4.2 MiB)
  • Minutes of meeting AGM 2023 (4.3 MiB)
  • Minutes of meeting AGM 2022 (3.8 MiB)
  • Minutes of meeting AGM 2021 (3.5 MiB)
  • Minutes of meeting AGM 2020 (3.0 MiB)
  • Protokoll zur Generalversammlung 2019 (3.4 MiB)
  • Protokoll zur Generalversammlung 2018 (3.9 MiB)
  • Protokoll zur Generalversammlung 2017 (3.1 MiB)
  • Protokoll zur Generalversammlung 2016 (1.8 MiB)
  • Protokoll zur Generalversammlung 2015 (2.1 MiB)
  • Protokoll zur Generalversammlung 2014 (3.1 MiB)
  • Protokoll zur Generalversammlung 2013 (747.1 KiB)
  • Protokoll zur Generalversammlung 2012 (434.4 KiB)
  • Protokoll zur Generalversammlung 2011 (1.4 MiB)
  • Protokoll zur Generalversammlung 2010 (1.2 MiB)
  • Protokoll zur Generalversammlung 2009 (354.2 KiB)
  • Protokoll zur Generalversammlung 2008 (391.6 KiB)
  • Protokoll zur Generalversammlung 2007 (367.8 KiB)
  • Protokoll zur Generalversammlung 2006 (201.5 KiB)
Order printed reports
TOP
Quick links
Skip navigation
  • Our products
  • Our expertise
  • About us
  • Sustainability
  • Investors
  • Media
  • Careers
  • Ypsomed Test Community
 
Legal & compliance
Skip navigation
  • Imprint
  • Terms of service
  • Data privacy and cookie policy
  • Certificates
  • Vulnerability disclosure
 
Resources & information
Skip navigation
  • Suppliers
  • Search
  • Sitemap
  • mylife Diabetes Care product resources
 
Contact

Ypsomed AG
Headquarters Burgdorf
Brunnmattstrasse 6
3401 Burgdorf
Switzerland

T +41 (0)34 424 41 11
F +41 (0)34 424 41 22
info@ypsomed.com

Subscribe to our newsletter

Follow us on
Page last update: 20.10.2025 - 11:38am © by Ypsomed
Ypsomed Logo